Klaus Metzeler

55PUBLICATIONS
246CO-AUTHORS
Haematological tumoursMedical mycologyEpigenetics (incl. genome methylation and epigenomics)AudiologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (55)

|Sep 16, 2026
Canakinumab or emavusertib for anemia in lower-risk MDS: results of the CANFIRE and LUCAS phase 2, open-label, multicenter trials.

|Aug 18, 2026
Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.

|Feb 09, 2026
Prognostic impact of myelodysplasia-related gene mutations in FLT3-ITD-mutated acute myeloid leukemia.

Rabea Mecklenbrauck, Angela Villaverde Ramiro, Eric Sträng

|Jan 28, 2026
Who Am I? Eyebrow Follicles Minimize Donor-Derived DNA for Germline Testing After Hematopoietic Stem Cell Transplantation.

Matthias Mertens, Mona Sadlo, Jörn-Sven Kühl

|Jan 14, 2026
Unravelling co-mutational patterns with prognostic implications in NPM1 mutated adult acute myeloid leukemia - a HARMONY study.

Alberto Hernández-Sánchez, Ángela Villaverde Ramiro, Eric Sträng

|Oct 28, 2025
Differential prognostic impact of myelodysplasia-related gene mutations in a European cohort of 4978 intensively treated AML patients.

Marius Bill, Jan-Niklas Eckardt, Konstanze Döhner

Pageof 10

Frequent Collaborators

22 joint publications

Uwe Platzbecker

15 joint publications

Madlen Jentzsch

14 joint publications

Tobias Herold

14 joint publications

Karsten Spiekermann